Literature DB >> 19801910

Blood hyaluronic acid as a marker for canine cirrhosis.

Hideyuki Kanemoto1, Koichi Ohno, Manabu Sakai, Ko Nakashima, Masashi Takahashi, Yasuhito Fujino, Hajime Tsujimoto.   

Abstract

Blood hyaluronic acid (HA) concentration was measured in dogs with various liver diseases to determine its relationship with histological fibrosis of the liver. The blood HA concentration significantly increased in dogs with chronic liver diseases compared with extrahepatic diseases and control. Furthermore, the median blood HA concentration in dogs with liver cirrhosis (500 microg/l; range, 151-1970 microg/l) was significantly higher than dogs with non-cirrhotic liver diseases (153 microg/l; range, 15-477 microg/l). In histochemical analysis, HA was distributed primarily in the fibrotic area in dogs with chronic liver diseases. As a conclusion, the blood HA concentration was significantly increased in dogs with chronic liver diseases, especially those with cirrhosis. Measurement of the blood HA levels of dogs with suspected liver disease can be a useful diagnostic aid for canine cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801910     DOI: 10.1292/jvms.71.1251

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  6 in total

1.  Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis.

Authors:  Jonathan A Lidbury; Aline Rodrigues Hoffmann; Joanna K Fry; Jan S Suchodolski; Jörg M Steiner
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

2.  Use of serum biomarkers in staging of canine hepatic fibrosis.

Authors:  Maud Menard; Alexis Lecoindre; Jean-Luc Cadoré; Michèle Chevallier; Aurélie Pagnon; Juan Hernandez; Rodolpho Oliveira Leal; Marine Hugonnard; Véronique Miette; Marie Destro; Benoît Rannou; Ghita Benchekroun; Patrick Lecoindre
Journal:  J Vet Diagn Invest       Date:  2019-07-26       Impact factor: 1.279

3.  Validation of a commercial human ELISA to measure hyaluronic acid concentration in feline plasma.

Authors:  Kaela E Shaw; Alexa M Bersenas; Shane W Bateman; Shauna L Blois; R Darren Wood
Journal:  J Vet Diagn Invest       Date:  2021-09-13       Impact factor: 1.279

4.  Usefulness of noninvasive shear wave elastography for the assessment of hepatic fibrosis in dogs with hepatic disease.

Authors:  Masahiro Tamura; Hiroshi Ohta; Genya Shimbo; Tatsuyuki Osuga; Noboru Sasaki; Keitaro Morishita; Yumiko Kagawa; Mitsuyoshi Takiguchi
Journal:  J Vet Intern Med       Date:  2019-08-28       Impact factor: 3.333

Review 5.  Hepatic Fibrosis in Dogs.

Authors:  V M Eulenberg; J A Lidbury
Journal:  J Vet Intern Med       Date:  2017-11-30       Impact factor: 3.333

6.  Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease.

Authors:  Chantel Raghu; Joanne Ekena; John M Cullen; Craig B Webb; Lauren A Trepanier
Journal:  J Vet Intern Med       Date:  2018-02-27       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.